Skip to content
Home/Companies/Biotech/SparingVision
SP

SparingVision

Biotech·France·Active·6yr hold

SparingVision is a healthcare company, headquartered in France.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns SparingVision?

SparingVision is currently owned by 4Bio Partners through 4BIO Ventures III (2022 vintage), since 2020. Across its history, SparingVision has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

4Bio Partners
Most recent investor
4Bio Partners
4BIO Ventures III · 2022 · Life Sciences VC
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by AdBio Partners, Jeito Capital and 4Bio Partners since 2019.
Co-invest · 3 holders · 2019 · present
AdBio Partners
AdBio PartnersActive
2019 · present · AFB Seed-Fund · 2017 · VC
MOIC
–
4Bio Partners
4Bio PartnersActive
2020 · present · 4BIO Ventures III · 2022 · Life Sciences VC
MOIC
–
Jeito Capital
Jeito CapitalActive
2020 · present · Jeito I · 2021 · VC
MOIC
–

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics
Active
BiotechUK· 2026
Actithera
Active
BiotechSwitzerland· 2025
Hornet Therapeutics
Active
BiotechUK· 2024
March Biosciences
Active
BiotechUS· 2024
Ascend Advanced Therapies
Active
BiotechUK· 2023
Trogenix
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings